GoodRx Holdings (GDRX) EBITDA US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA, bln rub | ? | -257.1 | 48.0 | 65.2 | 68.5 | 108.8 | 121.3 | ||
Changes by years, y/y, % | -273% | -119% | +36% | +5% | +59% | +4.5% |
GoodRx Holdings. EBITDA US GAAP, bln rub
GoodRx Holdings. EBITDA US GAAP, changes, %
GoodRx Holdings. EBITDA US GAAP, sum by quarters, bln rub
GoodRx Holdings (GDRX) EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
EBITDA, bln rub | ? | -5.31 | 34.9 | 36.3 | 36.8 | 13.3 | 121.3 | |
Changes by years, y/y, % | -558% | +54% | +15% | -13% | -351% | |||
Changes by quarters, q/q, % | -113% | -757% | +4% | +1% | -64% |